General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Drancourtella massiliensis is a Gram-positive, spore-forming, strictly anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 45.2%. Drancourtella massiliensis is probably a rare gut coloniser. (Durand2016)



  • This organism has been recovered from human faeces (Durand2016). Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Durand2016);
    Character Response
  • 🧂
  • Salt tolerance:
  • doesn't tolerate 1% salt;
  • pH
  • Acidity tolerance:
  • tolerates pH 6.5-7;
  • 🌡
  • Temperature tolerance:
  • Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • ribose; D-turanose; 5-ketogluconate; α-methyl glucoside;
  • Active enzymes:
  • N-Ac β-glucosaminidase; cystine arylamidase; β-galactosidase; Leu arylamidase; Val arylamidase; naphthol-ASBI-P;

  • SPECIAL FEATURES (Durand2016);
    Character Response
  • Metabolites not produced:
  • indole;
  • Haemolysis:
  • absent

  • RESPONSE TO ANTIBIOTICS (Durand2016);
    Class Active Resistant
  • Penicillins:
  • amoxicillin; imipenem; ticarcillin;
  • aztreonam;
  • Cephalosporins:
  • cefepime;
  • ceftazidime;
  • Quinolines:
  • ciprofloxacin; ofloxacin;
  • Aminoglycosides:
  • gentamicin;
  • amikacin; tobramycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • fosfomycin; metronidazole;
  • sulfamethoxazole;
  • Vancomycins:
  • vancomycin; teicoplanin;
  • Miscellaneous antibiotics:
  • clindamycin; linezolid; colistin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Clostridia Order:  Clostridiales Family:  Ruminococcaceae Genus:  Drancourtella Gram stain:  + O2 Relation.:  strictly anaerobic Spore:  Endospore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  human faeces (Durand2016)
    DNA G+C(%):  45.2
    Opt. T:  37℃
    NaCl 0.5-2%:  1(neg)
    pH 6.0-8.0:  6.5-7(+)

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Ribose:  + Turanose:  + 5-Ketogluconate:  + Me-α-D-Glc:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Ac-β-glcamnd:  + β-Galactosidase:  + CystineAA:  + LeuAA:  + ValAA:  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Indole:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  Sens
    aztreonam:  Res
    ticarcillin:  Sens
    imipenem:  Sens
    cefepime:  Sens
    ceftazidime:  Res
    amikacin:  Res
    gentamicin:  Sens
    tobramycin:  Res
    linezolid:  Sens
    ciprofloxacin:  Res
    ofloxacin:  Res
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    teicoplanin:  Sens
    vancomycin:  Sens
    rifampicin:  Sens
    fosfomycin:  Sens
    metronidazole:  Sens
    sulfamethoxazole:  Res
    clindamycin:  Sens
    colistin:  Sens

    References


    SPECIFIC REFERENCES FOR DRANCOURTELLA MASSILIENSIS
  • Durand2016 - Drancourtella massiliensis gen. nov., sp. nov. isolated from fresh healthy human faecal sample from South France.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR DRANCOURTELLA MASSILIENSIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................
  • GENERAL REFERENCES FOR DRANCOURTELLA MASSILIENSIS
  • Ludwig2009 - Revised road map to the phylum Firmicutes.